One such example is inhibition of the Phosphoinositode-3-kinase/AKT serine/threonine kinase (PI3K/AKT) pathway to increase the sensitivity and reverse acquired resistance of esophageal cancer cells to chemotherapeutic drugs (33). Here, MARK2 is linked to esophageal cancer.